Figure 2
From: A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine
Gemcitabine and top depleted genes. (a) Gemcitabine, 2′,2′-difluoro-2′-deoxycytidine (dFdC). (b) RIGER p-value position of the top five depleted genes.
